Moderna Wins Permission to Submit Coronavirus Vaccine Candidate for Fast-Track Approval in Europe
Fresh off its announcement that it has submitted its coronavirus vaccine candidate for regulatory approval in Canada, Moderna (NASDAQ: MRNA) said Wednesday it is in a similar situation in Europe. The company announced that the European Medicines Agency (EMA) has formally notified it that mRNA-1273 is eligible for submission of an application for fast-track approval.
If granted European Union Marketing Authorization, Moderna would be able to distribute the approved vaccine throughout the 27-country economic bloc that includes such nations as Germany and Spain.
Image source: Getty Images.
Source Fool.com
